• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Regenerative Medicine

Magenta Therapeutics rises on Street-beating Q4

March 3, 2021 By Sean Whooley Leave a Comment

Magenta Therapeutics (NSDQ:MGTA) shares ticked up today on fourth-quarter earnings that topped the consensus forecast. The Cambridge, Mass.-based stem cell transplantation technology developer posted losses of -$18.2 million, or -38¢ per share for the three months ended Dec. 31, 2020, marking a 21.8% bottom-line gain. Get the full story at our sister site, Drug Delivery Business […]

Filed Under: Business/Financial News, Drug-Device Combinations, MassDevice Earnings Roundup, Regenerative Medicine, Stem Cells, Wall Street Beat Tagged With: magentatherapeutics

Could this hydrogel repair a broken heart?

March 2, 2021 By Nancy Crotti Leave a Comment

European researchers have developed an injectable hydrogel that could help repair and prevent further heart muscle damage after a heart attack. The therapeutic effect of multiple injections of this hydrogel into the cardiac tissue was assessed during the first preclinical study of its kind, demonstrating its efficacy for cardiac tissue remodeling following a heart attack, […]

Filed Under: Cardiovascular, Featured, Regenerative Medicine, Research & Development Tagged With: hydrogel, National University of Ireland Galway, University of Gothenburg, University of Milano-Bicocca, University of Valladolid, University Paris Est

Locate Bio lands FDA breakthrough nod for bone infection device

January 7, 2021 By Nancy Crotti

Regenerative medicine company Locate Bio announced today that the FDA has granted breakthrough device designation to a bone graft/antibiotic combination designed to combat chronic bone infection, also known as osteomyelitis. Osteomyelitis is a progressive, inflammatory infection of the bone, usually caused by bacteria and is estimated to account for up to 50% of all non-trauma […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, Orthopedics, Regenerative Medicine, Regulatory/Compliance Tagged With: FDA, Locate Bio

Fibralign wins CE mark for BioBridge tissue repair device

September 15, 2020 By Sean Whooley

Stanford spin-out Fibralign announced that it received CE Mark approval in Europe for its BioBridge collagen matrix. Union City, Calif.-based Fibralign’s BioBridge has been designated as a Class III device with an indication for use in supporting lymphatic tissue repair and can be used after or in conjunction with surgical procedures addressing lymphedema, according to […]

Filed Under: Regenerative Medicine, Regulatory/Compliance Tagged With: CE Mark, Fibralign

Rosens Diversified is acquiring Collagen Solutions

August 27, 2020 By Sean Whooley

Rosen’s Diversified today agreed to a deal to acquire the entire issued and to-be-issued ordinary share capital of Collagen Solutions (LON:COS). Rosen’s Diversified (RDI) is a Fairmont, Minn.-based food production, agrichemical and distribution company that is already Collagen Solutions’ largest shareholder, according to a news release. Collagen Solutions, which has a U.K. headquarters and operates out […]

Filed Under: Business/Financial News, Featured, Implants, Mergers & Acquisitions, Orthopedics, Regenerative Medicine Tagged With: collagensolutions

Fibralign partners with Terumo

June 2, 2020 By Sean Whooley

Stanford spin-out Fibralign announced today that it entered into a long-term distributor agreement with Terumo for the BioBridge collagen matrix. The agreement is set to see Terumo market and distribute BioBridge collagen matrix, which is used to treat and prevent secondary lymphedema, in Japan. BioBridge is a sterile, implantable, biocompatible and biodegradable surgical mesh made […]

Filed Under: Business/Financial News, Distribution, Regenerative Medicine Tagged With: Fibralign, Terumo

Revian announces patent for LED hair-loss prevention tech

January 14, 2020 By Sean Whooley

Revian announced that the U.S. Patent & Trademark Office (USPTO) has issued the company a patent to use proprietary color combinations of light to regenerate living tissue in the body — including hair. The patent covers the use of specific wavelengths of LED light to stimulate the body’s cellular generation of nitric oxide as well […]

Filed Under: Cosmetic/Aesthetic, Featured, Legal News, Regenerative Medicine, Regulatory/Compliance Tagged With: Know Bio, Revian, U.S. Patent & Trademark Office (USPTO)

The 10 greatest medtech advances of the 2010s

January 2, 2020 By Chris Newmarker

From disposable endoscopes to TAVR to robotic surgery, there’s a whole host of medtech advances widely available now that weren’t around much 10 years ago. “In terms of technological advances, I would put this past decade as one of the most important for medical technology. From connected devices and robotics, to advances in material sciences […]

Filed Under: Business/Financial News, Cardiovascular, Diabetes, Digital Health, Drug-Device Combinations, Endoscopic, Featured, Neuromodulation/Neurostimulation, News Well, Orthopedics, Regenerative Medicine, Robotics, Surgical Tagged With: 3D printing, Abbott, artificial intelligence, Bigfoot Biomedical, Boston Scientific, Carbon, Edwards Lifesciences, Frequency Therapeutics, Insulet, Johnson & Johnson, Medtronic, NeuroPace, Nevro Corp., robot-assisted, Smith & Nephew, Stryker, tavr

Mayo Clinic, W.L. Gore team up on stem cell therapy treatments

December 11, 2019 By Nancy Crotti

Mayo Clinic and W. L. Gore & Associates have announced a partnership to develop implantable cell therapies to treat debilitating conditions with no cure. The for-profit company, Avobis Bio, will combine a patient’s own stem cells with bioabsorbable scaffolds to stimulate the healing of perianal fistulas, painful tunneling wounds that affect patients with Crohn’s disease. […]

Filed Under: Business/Financial News, Featured, Implants, Regenerative Medicine, Research & Development, Stem Cells, Surgical, Wound Care Tagged With: Avobis Bio, Mayo Clinic, W.L. Gore & Associates

5 ways medtech research aims to help veterans

November 7, 2019 By Nancy Crotti

As the United States prepares to honor its military veterans on Monday, medtech researchers are working to help survivors wounded in battle, both in body and mind. Whether the research comes out of government, industry or academia, there’s also a desire to help veterans facing other health challenges. Get the full story on our sister […]

Filed Under: Big Data, Electronic Medical Records (EMR), Featured, Imaging, Neurological, News Well, Regenerative Medicine, Research & Development, Respiratory, Surgical, Transplants, Wound Care Tagged With: DARPA, stratasys, U.S. Department of Veterans Affairs

Admedus deals biologic patch business to LeMaitre Vascular for $24m

October 15, 2019 By Brad Perriello

Admedus (ASX:AHZ) dealt its biologic patch business to LeMaitre Vascular (NSDQ:LMAT) in a deal worth up to $24.6 million to focus on the transcatheter aortic valve replacement market. The A$36.2 million buyout of the CardioCel and VascuCel patches called for LeMaitre to put up $14.2 million up front, with another $1.4 million due in a pair […]

Filed Under: Featured, Mergers & Acquisitions, Regenerative Medicine, Vascular, Wall Street Beat, Wound Care Tagged With: Admedus Ltd., LeMaitre Vascular Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 53
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS